PARADISI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 383
EU - Europa 261
AS - Asia 198
SA - Sud America 25
AF - Africa 1
Totale 868
Nazione #
US - Stati Uniti d'America 375
SG - Singapore 68
IT - Italia 54
CN - Cina 53
IE - Irlanda 45
RU - Federazione Russa 37
DE - Germania 36
SE - Svezia 32
TR - Turchia 28
BR - Brasile 22
VN - Vietnam 19
GB - Regno Unito 16
HK - Hong Kong 15
UA - Ucraina 13
FR - Francia 8
FI - Finlandia 6
CA - Canada 5
IN - India 5
NL - Olanda 5
CZ - Repubblica Ceca 4
BD - Bangladesh 3
MX - Messico 3
AR - Argentina 2
JP - Giappone 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
EE - Estonia 1
ET - Etiopia 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 868
Città #
Jacksonville 48
Dallas 45
Dublin 45
Singapore 45
Chandler 43
San Jose 42
Ashburn 28
Boardman 17
Hong Kong 15
Izmir 14
Santa Clara 14
L'aquila 13
Nanjing 13
The Dalles 9
Beijing 8
Munich 8
Bremen 6
Lawrence 6
Los Angeles 6
Moscow 6
New York 6
Princeton 6
Berlin 5
Lauterbourg 5
Milan 5
Shenyang 5
Amsterdam 4
Brno 4
Ho Chi Minh City 4
Rome 4
San Mateo 4
Wilmington 4
Woodbridge 4
Atlanta 3
Falkenstein 3
Hanoi 3
Hebei 3
Manchester 3
Phoenix 3
Redwood City 3
Aquila 2
Brasília 2
Brooklyn 2
Da Nang 2
Dong Ket 2
Istanbul 2
Joinville 2
Montreal 2
Mountain View 2
Orem 2
Qingdao 2
Querétaro 2
São Paulo 2
Taizhou 2
Tianjin 2
Tokyo 2
Verona 2
Warsaw 2
Aberdeen 1
Addis Ababa 1
Alegrete 1
Arzignano 1
Bangkok 1
Bertioga 1
Boston 1
Buffalo 1
Bắc Ninh 1
Calgary 1
Cao Lanh 1
Chennai 1
Chicago 1
Cleveland 1
Columbus 1
Córdoba 1
Diadema 1
Franca 1
Fremont 1
Gia Nghĩa 1
Grafing 1
Gujranwala 1
Helsinki 1
Honolulu 1
Igarapé 1
Irwin 1
Jaraguá do Sul 1
Jeddah 1
Jinan 1
Juiz de Fora 1
Jundiaí 1
Kilis 1
Kunming 1
Lima 1
Manhuaçu 1
Mendoza 1
Minneapolis 1
Mumbai 1
Nanchang 1
Ninh Bình 1
Norwalk 1
Nova Iguaçu 1
Totale 590
Nome #
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 169
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 166
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 166
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 148
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 122
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 111
Totale 882
Categoria #
all - tutte 3.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 3 10 5
2021/202243 3 0 17 3 0 1 0 1 2 0 3 13
2022/2023133 6 12 0 21 14 7 0 8 58 1 3 3
2023/202440 4 2 0 0 4 8 0 3 0 0 6 13
2024/2025125 4 8 16 7 11 14 23 6 21 2 12 1
2025/2026286 15 36 23 50 35 31 40 5 22 29 0 0
Totale 882